Abstract:Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) are related neurodegenerative diseases that belong to a common disease spectrum based on overlapping clinical, pathological and genetic evidence. Early pathological changes to the morphology and synapses of affected neuron populations in ALS/FTD suggest a common underlying mechanism of disease that requires further investigation. Fused in sarcoma (FUS) is a DNA/RNA-binding protein with known genetic and pathological links to ALS/FTD. Expression of ALS-linked FUS mutants in mice causes cognitive and motor defects, which correlate with loss of motor neuron dendritic branching and synapses, in addition to other pathological features of ALS/FTD. The role of ALS-linked FUS mutants in causing ALS/FTD-associated disease phenotypes is well established, but there are significant gaps in our understanding of the cell-autonomous role of FUS in promoting structural changes to motor neurons, and how these changes relate to disease progression. Here we generated a neuron-specific FUS-transgenic mouse model expressing the ALS-linked human FUSR521G variant, hFUSR521G/Syn1, to investigate the cell-autonomous role of FUSR521G in causing loss of dendritic branching and synapses of motor neurons, and to understand how these changes relate to ALS-associated phenotypes. Longitudinal analysis of mice revealed that cognitive impairments in juvenile hFUSR521G/Syn1 mice coincide with reduced dendritic branching of cortical motor neurons in the absence of motor impairments or changes in the neuromorphology of spinal motor neurons. Motor impairments and dendritic attrition of spinal motor neurons developed later in aged hFUSR521G/Syn1 mice, along with FUS cytoplasmic mislocalisation, mitochondrial abnormalities and glial activation. Neuroinflammation promotes neuronal dysfunction and drives disease progression in ALS/FTD. The therapeutic effects of inhibiting the pro-inflammatory nuclear factor kappa B (NF-κB) pathway with an analog of Withaferin A, IMS-088, were assessed in symptomatic hFUSR521G/Syn1 mice and were found to improve cognitive and motor function, increase dendritic branches and synapses of motor neurons, and attenuate other ALS/FTD-associated pathological features. Treatment of primary cortical neurons expressing FUSR521G with IMS-088 promoted the restoration of dendritic mitochondrial numbers and mitochondrial activity to wild-type levels, suggesting that inhibition of NF-κB permits the restoration of mitochondrial stasis in our models. Collectively, this work demonstrates that FUSR521G has a cell-autonomous role in causing early pathological changes to dendritic and synaptic structures of motor neurons, and that these changes precede motor defects and other well-known pathological features of ALS/FTD. Finally, these findings provide further support that modulation of the NF-κB pathway in ALS/FTD is an important therapeutic approach to attenuate disease.

Deficiency of Alpha 1,6-Fucosyltransferase Promotes Neuroinflammation by Increasing the Sensitivity of Glial Cells to Inflammatory Mediators

Fucosyltransferase 8 regulates adult neurogenesis and cognition of mice by modulating the Itga6-PI3K/Akt signaling pathway

The role of FUT8‐catalyzed core fucosylation in Alzheimer's amyloid‐β oligomer‐induced activation of human microglia

FUT8 Regulates Cerebellar Neurogenesis and Development Through Maintaining the Level of Neural Cell Adhesion Molecule Cntn2

Altered fucosyltransferase expression in the superior temporal gyrus of elderly patients with schizophrenia

Microglial Glutaminase 1 Deficiency Mitigates Neuroinflammation Associated Depression.

Interferon Regulatory Factor 5 Mediates Lipopolysaccharide-Induced Neuroinflammation

Ablation of Core Fucosylation Attenuates the Signal Transduction Via T Cell Receptor to Suppress the T Cell Development.

Loss of core fucosylation reduces low-density lipoprotein receptor expression in hepatocytes by inducing PCSK9 production

An Immunomodulatory Role of Fc Receptor Γ Chain Independent of FcγR Ligation by IgG in Acute Neuroinflammation Triggered by MPTP Intoxication.

Roles of Core Fucosylation Modification in Immune System and Diseases

Inhibition of Core Fucosylation Limits Progression of Diabetic Kidney Disease.

Intestinal α1-2-Fucosylation Contributes to Obesity and Steatohepatitis in Mice

Dcf1 Deficiency Attenuates the Role of Activated Microglia During Neuroinflammation.

Neuronal dysfunction caused by FUSR521G promotes ALS-associated phenotypes that are attenuated by NF-κB inhibition

A1 astrocytes contribute to murine depression-like behavior and cognitive dysfunction, which can be alleviated by IL-10 or fluorocitrate treatment

FKBP51 is involved in LPS-induced microglial activation via NF-κB signaling to mediate neuroinflammation

Fucosylation Deficiency in Mice Leads to Colitis and Adenocarcinoma

Deficiency of Intestinal Α1‐2‐fucosylation Exacerbates Ethanol‐Induced Liver Disease in Mice

Microglial Ffar4 deficiency promotes cognitive impairment in the context of metabolic syndrome

Α-1, 6-Fucosyltransferase and Tumor: Recent Progress